Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127534681 | 12753468 | 1 | I | 20160902 | 20160916 | 20160916 | EXP | US-LUPIN PHARMACEUTICALS INC.-2016-04153 | LUPIN | MIESNER A, AUSMAN M, DAGRAEDT B, ZIEMINSKI J. PROBABLE DRUG INTERACTION BETWEEN EVEROLIMUS AND CLARITHROMYCIN. ANNALS OF PHARMACOTHERAPY. 2016;50(8):689-690. | 56.00 | YR | M | Y | 0.00000 | 20160916 | PH | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127534681 | 12753468 | 1 | PS | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Oral | UNKNOWN | 202532 | 500 | MG | BID | |||||||
127534681 | 12753468 | 2 | I | Everolimus | EVEROLIMUS | 1 | Oral | 10 MG | UNKNOWN | 0 | |||||||||
127534681 | 12753468 | 3 | I | Everolimus | EVEROLIMUS | 1 | Oral | 5 MG | UNKNOWN | 0 | |||||||||
127534681 | 12753468 | 4 | C | AMOXICILLIN. | AMOXICILLIN | 1 | Oral | 0 | 500 | MG | BID | ||||||||
127534681 | 12753468 | 5 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 40 MG | 0 | ||||||||||
127534681 | 12753468 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 0 | 40 | MG | QOD | ||||||||
127534681 | 12753468 | 7 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 200 MICROGRAM | 0 | ||||||||||
127534681 | 12753468 | 8 | C | METOPROLOL SUCCINATE. | METOPROLOL SUCCINATE | 1 | Oral | 25 MG | 0 | ||||||||||
127534681 | 12753468 | 9 | C | CALCIUM GLUCONATE. | CALCIUM GLUCONATE | 1 | Unknown | 0 | |||||||||||
127534681 | 12753468 | 10 | C | Insulin | INSULIN NOS | 1 | Unknown | 0 | |||||||||||
127534681 | 12753468 | 11 | C | SODIUM POLYSTYRENE SULFONATE. | SODIUM POLYSTYRENE SULFONATE | 1 | Unknown | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127534681 | 12753468 | 1 | Helicobacter infection |
127534681 | 12753468 | 2 | Clear cell renal cell carcinoma |
127534681 | 12753468 | 4 | Helicobacter infection |
127534681 | 12753468 | 5 | Helicobacter infection |
127534681 | 12753468 | 6 | Product used for unknown indication |
127534681 | 12753468 | 7 | Product used for unknown indication |
127534681 | 12753468 | 8 | Product used for unknown indication |
127534681 | 12753468 | 9 | Product used for unknown indication |
127534681 | 12753468 | 10 | Product used for unknown indication |
127534681 | 12753468 | 11 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127534681 | 12753468 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127534681 | 12753468 | Acute kidney injury | |
127534681 | 12753468 | Drug interaction |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |